[Tacrolimus ointment for the treatment of atopic dermatitis].

The topical immunomodulator tacrolimus ointment has been shown to be safe and effective in the treatment of atopic dermatitis in clinical trials involving over 16,000 patients. Clinical trial results focusing on tacrolimus' safety and efficacy are summarized. Minimal systemic absorption results from topical application in patients with atopic dermatitis. Although the exact mechanism of action of tacrolimus ointment in atopic dermatitis is unknown, tacrolimus is known to inhibit up-regulation of cytokine production following T cell activation and to decrease Fc epsilon RI expression on dendritic antigen-presenting cells in skin. Additional mechanisms of action of tacrolimus relevant in the pathogenesis of inflammatory skin disorders are discussed.

[1]  J. Saurat,et al.  Eczema herpeticum during Treatment of Atopic Dermatitis with 0.1% Tacrolimus Ointment , 2000, Dermatology.

[2]  K. Nishioka,et al.  Topical tacrolimus is effective for facial lesions of psoriasis. , 2000, Acta dermato-venereologica.

[3]  J. Walker-Smith,et al.  Topical tacrolimus may be effective in the treatment of oral and perineal Crohn's disease , 2000, Gut.

[4]  M. Lahfa,et al.  Safety and Efficacy of 1 Year of Tacrolimus Ointment Monotherapy in Adults With Atopic Dermatitis , 2000 .

[5]  J. Popay,et al.  The epidemiology and experience of atopic eczema during childhood: a discussion paper on the implications of current knowledge for health care, public health policy and research , 2000, Journal of epidemiology and community health.

[6]  T. Ruzicka,et al.  Applications of tacrolimus for the treatment of skin disorders. , 2000, Immunopharmacology.

[7]  Y. Suga,et al.  A case of ichthyosis linearis circumflexa successfully treated with topical tacrolimus. , 2000, Journal of the American Academy of Dermatology.

[8]  J. Hanifin,et al.  Update on therapy of atopic dermatitis. , 1999, The Journal of allergy and clinical immunology.

[9]  A. Remitz,et al.  Tacrolimus ointment improves psoriasis in a microplaque assay , 1999, The British journal of dermatology.

[10]  J. Hanifin,et al.  Biochemical and immunologic mechanisms in atopic dermatitis: new targets for emerging therapies. , 1999, Journal of American Academy of Dermatology.

[11]  A. Kemp.  Atopic eczema: Its social and financial costs , 1999, Journal of paediatrics and child health.

[12]  T. Ruzicka,et al.  Tacrolimus: the drug for the turn of the millennium? , 1999, Archives of dermatology.

[13]  Vente,et al.  Erosive mucosal lichen planus: response to topical treatment with tacrolimus , 1999, The British journal of dermatology.

[14]  T. Bieber.  Topical tacrolimus (FK 506): a new milestone in the management of atopic dermatitis. , 1998, The Journal of allergy and clinical immunology.

[15]  M. Boguniewicz,et al.  A randomized, vehicle-controlled trial of tacrolimus ointment for treatment of atopic dermatitis in children. Pediatric Tacrolimus Study Group. , 1998, The Journal of allergy and clinical immunology.

[16]  P. Autio,et al.  Tacrolimus ointment does not affect collagen synthesis: results of a single-center randomized trial. , 1998, The Journal of investigative dermatology.

[17]  L. Dubertret,et al.  Topical tacrolimus is not effective in chronic plaque psoriasis. A pilot study. , 1998, Archives of dermatology.

[18]  H. Nakagawa,et al.  Tacrolimus concentrations in blood during topical treatment of atopic dermatitis , 1996, The Lancet.

[19]  H. Tagami,et al.  Successful treatment of resistant facial lesions of atopic dermatitis with 0.1% FK506 ointment , 1995, The British journal of dermatology.

[20]  D. Schwarz,et al.  Atopic dermatitis in children: who cares? Who pays? , 1993, Journal of the American Academy of Dermatology.

[21]  I. Bekersky,et al.  Nonclinical and early clinical development of tacrolimus ointment for the treatment of atopic dermatitis. , 2001, Journal of the American Academy of Dermatology.

[22]  A. Fleischer,et al.  Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: part II, safety. , 2001, Journal of the American Academy of Dermatology.

[23]  R. Langley,et al.  Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: part I, efficacy. , 2001, Journal of the American Academy of Dermatology.

[24]  A. Paller,et al.  A 12-week study of tacrolimus ointment for the treatment of atopic dermatitis in pediatric patients. , 2001, Journal of the American Academy of Dermatology.

[25]  K. Beusterien,et al.  The impact of tacrolimus ointment on health-related quality of life of adult and pediatric patients with atopic dermatitis. , 2001, Journal of the American Academy of Dermatology.

[26]  D. Abeck,et al.  Optimal Management of Atopic Dermatitis , 2000, American journal of clinical dermatology.

[27]  J. Hanifin,et al.  Old, new, and emerging therapies for atopic dermatitis. , 2000, Dermatologic clinics.

[28]  Ttila,et al.  A short-term trial of tacrolimus ointment for atopic dermatitis , 2000 .

[29]  H. Williams,et al.  Systematic review of treatments for atopic eczema. , 2000, Health technology assessment.

[30]  D. Strachan,et al.  Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood. , 1999, The Journal of allergy and clinical immunology.

[31]  H. Maibach,et al.  Absorption of topical tacrolimus (FK506) in vitro through human skin: comparison with cyclosporin A. , 1997, Skin pharmacology : the official journal of the Skin Pharmacology Society.